ChemTrak Inc. said it resumed shipments of its cholesterol test,which were suspended last month after a manufacturingproblem surfaced.
The Sunnyvale, Calif., company said that the problem with itsAccuMeter Total Cholesterol Test has been identified andisolated and that quality-control measures are in place toprevent a recurrence.
The company (NASDAQ:CMTR) said it will report a loss ofbetween $3 million and $3.3 million for the quarter ended June30, compared with a $996,000 loss for the comparable periodin 1991. ChemTrak said it will report revenues of about$300,000 for the 1992 period.
The AccuMeter cholesterol test, available in the U.S. since May1991 through physicians, is a do-it-yourself test that providesa quantitative measurement of cholesterol in the blood.
(c) 1997 American Health Consultants. All rights reserved.